Department of Internal Medicine, Infectious Disease Unit, Tampere University Hospital, Tampere, Finland.
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Infect Dis (Lond). 2023 Jun;55(6):405-414. doi: 10.1080/23744235.2023.2192287. Epub 2023 Apr 8.
(Group A , GAS) is an important human pathogen that can cause severe invasive (iGAS) infections. Throat carriage has been assumed to possibly lead to hematogenous seeding. Retrospective studies may estimate the incidence of throat carriage in iGAS patients inaccurately. In this study we aimed to gather data on the presence of GAS in the throat among iGAS patients in a prospective setting.
We conducted a prospective clinical study covering iGAS infections in adult patients in two university hospitals in Finland from June 2018 to July 2020. Recruited patients' throats were swabbed for culture and isothermal amplification tests (IAT) to search for GAS. The study was registered at ClinicalTrials.gov as ID NCT03507101.
We enrolled 45 patients. Throat swabs were obtained from 39/45 (87%) patients. Ten patients (22%) had a positive IAT for GAS. They were statistically significantly more likely to be male (9/10 [90%] vs 13/29 [45%], = .024). Several different types caused the iGAS infections.
GAS was frequently observed in throat swabs of patients with iGAS infection. This may suggest that hematogenous seeding from the nasopharynx is a possible portal of entry.
(A 组,酿脓链球菌)是一种重要的人类病原体,可导致严重的侵袭性(iGAS)感染。咽携带被认为可能导致血源性播种。回顾性研究可能不准确地估计 iGAS 患者的咽携带发生率。在这项研究中,我们旨在前瞻性地收集 iGAS 患者咽携带酿脓链球菌的数据。
我们进行了一项前瞻性临床研究,涵盖了 2018 年 6 月至 2020 年 7 月芬兰两家大学医院的成年 iGAS 感染患者。招募的患者咽部进行了培养和等温扩增试验(IAT)以搜索酿脓链球菌。该研究在 ClinicalTrials.gov 上注册为 ID NCT03507101。
我们共纳入 45 例患者。39/45(87%)例患者获得了咽拭子。10 例患者(22%)的 IAT 对酿脓链球菌呈阳性。他们更有可能是男性(9/10 [90%] 比 13/29 [45%],=0.024)。多种不同类型导致了 iGAS 感染。
iGAS 感染患者的咽拭子中经常观察到酿脓链球菌。这可能表明鼻咽部的血源性播种是一个可能的入口。